Retail Roundup

Monday, December 5, 2016

This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:

  • DIR fees
  • Pharmacist provider status
  • Telehealth
  • Hospital-retail partnerships
  • Biosimilars
  • Opioid epidemic

Subscribe and Download this Podcast on iTunes

Visit iTunes Channel

You may also like:

Blog Post

Since 2000, more than 300,000 Americans have died from overdose involving opioids, according to the U.S. government. Recently, President Trump declared opioid abuse a national public emergency. In an effort to address this issue, ...

View Blog Post
Blog Post

Codeine remains a commonly prescribed analgesic after third molar surgery, despite evidence it may not be an effective pain treatment. It would be beneficial to patients and providers if it could be shown that codeine is not neces...

View Blog Post
Blog Post

Shortly after the New Year kicked off, I had the opportunity to participate in one of my favorite organization’s annual meetings: The American Society of Automation in Pharmacy (ASAP). ...

View Blog Post

RxPerts Academy

Stay in the Know

Sign up to start receiving notifications via email of our upcoming webinars!

Sign Up